Daniel Torres

UBS analysts initates a Neutral rating for Alpine Income Property Trust Inc (PINE)
Alpine Income Property Trust Inc’s recent filing unveils that its Director Richardson Andrew C unloaded Company’s shares for reported $17110.0 ...

Vor Biopharma Inc (VOR) rating initates by TD Cowen
In a filing, Vor Biopharma Inc revealed its Director RA CAPITAL MANAGEMENT, L.P. unloaded Company’s shares for reported $6.34 million ...

Palo Alto Networks Inc (PANW) Becoming More Attractive for Investors
Palo Alto Networks Inc’s filing revealed that its Director GOETZ JAMES J unloaded Company’s shares for reported $2.44 million on ...

CAMP4 Therapeutics Corp [CAMP] Insider Activity: An Update for Investors
CAMP4 Therapeutics Corp’s recently made public that its 10% Owner 5AM Partners VI, LLC acquired Company’s shares for reported $4.5 ...

Heritage Financial Corp (HFWA) may enjoy gains as insiders got busy in the recent days
Heritage Financial Corp’s recent filing unveils that its President McDonald Bryan acquired Company’s shares for reported $0.43 million on Nov ...

Taking a Closer Look At Halozyme Therapeutics Inc (HALO) Following Its Recent Trade
In a filing, Halozyme Therapeutics Inc revealed its SVP, CHIEF OPERATING OFFICER Caudill Cortney unloaded Company’s shares for reported $0.28 ...

Investing in Amaze Holdings Inc (AMZE): What You Must Know
Amaze Holdings Inc’s filing revealed that its Chief Executive Officer Day Aaron acquired Company’s shares for reported $0.1 million on ...

PVH Corp (PVH) receives a Market perform rating from Telsey Advisory Group
PVH Corp’s recently made public that its Chief Executive Officer Larsson Stefan acquired Company’s shares for reported $1.0 million on ...

Keeping an Eye on The Baldwin Insurance Group Inc (BWIN) After Insider Trading Activity
The Baldwin Insurance Group Inc’s recent filing unveils that its insider Roche James Morgan unloaded Company’s shares for reported $2.42 ...

Examining the Potential Price Growth of CRISPR Therapeutics AG (CRSP)
In a filing, CRISPR Therapeutics AG revealed its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $3.46 million ...





